Found: 69
Select item for more details and to access through your institution.
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery.
- Published in:
- Diabetes Care, 2024, v. 47, n. 9, p. 1682, doi. 10.2337/dc24-0838
- By:
- Publication type:
- Article
Non‐adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): Results of a post‐approval observational study.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 2, p. 1, doi. 10.1111/dme.14739
- By:
- Publication type:
- Article
Reduced hypoglycaemia using liver‐targeted insulin in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1762, doi. 10.1111/dom.14761
- By:
- Publication type:
- Article
Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1148, doi. 10.1111/dom.13205
- By:
- Publication type:
- Article
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 11, p. 1933, doi. 10.1007/s13300-023-01476-4
- By:
- Publication type:
- Article
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 5, p. 883, doi. 10.1007/s13300-023-01400-w
- By:
- Publication type:
- Article
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers.
- Published in:
- Pediatric Diabetes, 2023, p. N.PAG, doi. 10.1155/2023/8867625
- By:
- Publication type:
- Article
Continuous glucose monitoring in 2011.
- Published in:
- International Journal of Clinical Practice (Supplement), 2012, v. 66, p. 8, doi. 10.1111/j.1742-1241.2011.02848.x
- By:
- Publication type:
- Article
236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-236-OR
- By:
- Publication type:
- Article
149-OR: Evaluation of the Next Generation 180-Day Long-Term Implantable Eversense CGM System: PROMISE Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-149-OR
- By:
- Publication type:
- Article
96-LB: Glycemic Management over 6 Months with the Omnipod 5 Automated Insulin Delivery System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-96-LB
- By:
- Publication type:
- Article
94-LB: IV Insulin via Glucommander, an Electronic Glycemic Management System (eGMS) Demonstrates Low Rates of Hypoglycemia in Patients with Low Glomerular Filtration Rate (GFR) Compared with Other eGMS.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-94-LB
- By:
- Publication type:
- Article
716-P: Transition from Multiple Daily Injections (MDI) to Omnipod 5 Automated Insulin Delivery System Improves A1C in Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-716-P
- By:
- Publication type:
- Article
711-P: Glycemic Outcomes for Adult Type 1 Diabetes (T1D) with and without DKA Treated with an Electronic Glycemic Management System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-711-P
- By:
- Publication type:
- Article
70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-70-OR
- By:
- Publication type:
- Article
1276-P: First Home Evaluation of the Omnipod Horizon Automated Glucose Control System in Children with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1276-P
- By:
- Publication type:
- Article
984-P: First Home Evaluation of the Omnipod Horizon Automated Glucose Control System in Adults with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-984-P
- By:
- Publication type:
- Article
983-P: First Home Evaluation of the Omnipod Horizon Automated Glucose Control System at Specific Glucose Targets in Adults with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-983-P
- By:
- Publication type:
- Article
97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-97-LB
- By:
- Publication type:
- Article
7-LB: Insulin and Glucagon Coadministration in Type 1 Diabetes Prevents Hypoglycemia without Worsening Hyperglycemia.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-7-LB
- By:
- Publication type:
- Article
116-LB: Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes Using Continuous Glucose Monitoring.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-116-LB
- By:
- Publication type:
- Article
345-OR: First Home Evaluation of the Omnipod Horizon Automated Glucose Control System at Specific Glucose Targets in Children with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-345-OR
- By:
- Publication type:
- Article
278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-278-OR
- By:
- Publication type:
- Article
233-OR: Ultra-Rapid Lispro (URLi) Demonstrates Similar Time-in-Target Range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-233-OR
- By:
- Publication type:
- Article
111-LB: Hepatic Insulin Delivery to Minimize Hypoglycemic Events in Persons with Type 1 Diabetes: The OPTI-1 Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-111-LB
- By:
- Publication type:
- Article
983-P: Effect and Safety of Flexible Dose Adjustment with Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-983-P
- By:
- Publication type:
- Article
67-LB: Time Spent in Glycaemic Ranges and Carbohydrate Intake during Cycling in Professional Cyclists with Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-67-LB
- By:
- Publication type:
- Article
66-LB: Greater Time Spent in Hypoglycemia during Night Compared with Day during Intensified Training in Professional Cyclists with Type 1 Diabetes—A Prospective Observational Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-66-LB
- By:
- Publication type:
- Article
599-P: Diabetic Retinopathy (DR) Screening Performance of General Ophthalmologists, Retina Specialists, and Artificial Intelligence (AI): Analysis from a Pivotal Multicenter Prospective Clinical Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-599-P
- By:
- Publication type:
- Article
37-LB: Diabetic Retinopathy (DR) Screening Performance of an Artificial Intelligence (AI) System: Analysis from a Pivotal Multicenter Prospective Clinical Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-37-LB
- By:
- Publication type:
- Article
1089-P: Ultra Rapid Lispro (URLi) Improves Postprandial Glucose (PPG) Control and Time in Range (TIR) in T1D Compared with Humalog (Lispro): PRONTO-T1D Continuous Glucose Monitoring (CGM) Substudy.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1089-P
- By:
- Publication type:
- Article
1084-P: Divergent Hypoglycemic Effects of Hepatic Directed Prandial Insulin: A 6-Month Study in Type 1 Diabetes Mellitus (T1DM).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1084-P
- By:
- Publication type:
- Article
1059-P: Glycemic Outcomes from the MiniMed<sup>™ </sup>670G System Pivotal Trials in Patients 2-75 Years of Age.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1059-P
- By:
- Publication type:
- Article
1061-P: Effect of the Omnipod<sup>®</sup> Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1061-P
- By:
- Publication type:
- Article
Transition from IV to SC Insulin with Optimal BG Control Following CV Surgery.
- Published in:
- Diabetes, 2007, v. 56, p. A88
- By:
- Publication type:
- Article
Sensor Augmented Pump Therapy: Results of the First Treat-to-Target Study.
- Published in:
- Diabetes, 2007, v. 56, p. A24
- By:
- Publication type:
- Article
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
New Opportunities for Therapeutic Changes With Continuous Glucose Sensing.
- Published in:
- Diabetes Spectrum, 2000, v. 13, n. 3, p. 171
- By:
- Publication type:
- Article
Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2001, v. 24, n. 1, p. 69, doi. 10.2337/diacare.24.1.69
- By:
- Publication type:
- Article
Reduction in Severe Hypoglycemia With Long-Term Continuous-Subcutaneous Insulin Infusion in Type I Diabetes.
- Published in:
- Diabetes Care, 1996, v. 19, n. 4, p. 324, doi. 10.2337/diacare.19.4.324
- By:
- Publication type:
- Article
Diabetes management in the new millennium using insulin pump therapy.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study.
- Published in:
- Drugs - Real World Outcomes, 2020, v. 7, n. 1, p. 31, doi. 10.1007/s40801-019-00173-8
- By:
- Publication type:
- Article
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
- Published in:
- Diabetes Care, 2023, v. 46, n. 4, p. 742, doi. 10.2337/dc22-1915
- By:
- Publication type:
- Article
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.
- Published in:
- 2018
- By:
- Publication type:
- letter